Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 201

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

Open access
Sacco, Kristi A., Bannon, Katie L., George, Tony P.·2004·Journal of Psychopharmacology

Abstract

Cigarette smoking rates in the American population are approximately 23%, whereas rates of smoking in clinical and population studies of individuals with neuropsychiatric disorders are typically two- to four-fold higher. Studies conducted in a variety of neuropsychiatric populations [e.g. attention-deficit hyperactivity disorder (ADHD), Alzheimer’s disease, schizophrenia] have collectively suggested that nicotine may be efficacious in remediating selected cognitive deficits associated with these disorders, thus providing a framework for understanding the specific vulnerability of these patients to smoking initiation and maintenance. However, the specific gain in cognitive performance produced by nicotine administration in healthy subjects with normal cognitive function is less clear. This article reviews our current understanding of central nicotinic acetylcholine receptor (nAChRs) systems in normal and neuropsychiatric disease states and, specifically, their role with respect to cognitive dysfunction and clinical symptoms in several specific neuropsychiatric populations, including ADHD, Alzheimer’s disease, Parkinson’s disease, Tourette’s Disorder, schizophrenia and affective disorders. The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881104047273

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 176

  1. 10.1177/01454455960204001 · DOI
  2. 10.1176/ajp.150.12.1856 · DOI · Paper page
  3. 10.2165/00002512-199711060-00004 · DOI
  4. 10.1038/sj.npp.1300265 · DOI
  5. 10.1016/S0166-2236(00)01716-1 · DOI · Paper page
  6. 10.1016/0091-3057(85)90139-X · DOI · Paper page
  7. 10.1212/WNL.30.8.839 · DOI
  8. 10.1080/02791072.1999.10471731 · DOI
  9. Beckham J C, 1995, Addict Behav, 20, 1, 10.1016/0306-4603(94)00037-Y · DOI
  10. 10.1002/jts.2490080308 · DOI
  11. 10.1016/S0306-4603(96)00071-8 · DOI · Paper page
  12. 10.1080/14622299050011141 · DOI · Paper page
  13. 10.1016/0304-3940(92)90179-B · DOI
  14. 10.1007/978-3-7091-0643-3_11 · DOI
  15. Breese C R, 1997, J Pharmacol Exp Ther, 282, 7
  16. 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
  17. 10.1212/WNL.43.2.293 · DOI · Paper page
  18. 10.1001/archpsyc.56.12.1141 · DOI · Paper page
  19. 10.1016/S1353-8020(03)00028-2 · DOI
  20. 10.1007/BF02245195 · DOI
  21. Conners C K, 1995, The Continuous Performance Test
  22. Conners C K, 1996, Psychopharmacol Bull, 32, 67
  23. 10.1192/bjp.179.1.35 · DOI
  24. 10.1016/S0006-3223(00)01116-1 · DOI · Paper page
  25. 10.1016/S0006-3223(00)01101-X · DOI · Paper page
  26. 10.1176/ajp.155.11.1490 · DOI · Paper page
  27. 10.1080/14622200210141635 · DOI
  28. Delagarza V W, 2003, Am Family Phys, 68, 1365
  29. 10.1007/s002130050631 · DOI
  30. 10.1177/026988119901300106 · DOI
  31. 10.1016/S0893-133X(02)00372-X · DOI · Paper page
  32. Donnelly Roberts D L, 1998, J Pharmacol Exp Ther, 285, 777
  33. 10.1007/s002130100719 · DOI
  34. 10.1017/S0033291796003984 · DOI
  35. 10.1124/mol.64.6.1283 · DOI
  36. 10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F · doi:10.1002/1531-8257(199911)14:6<1011::aid-mds1016>3.0.co;2-f
  37. 10.1007/BF02806011 · doi:10.1007/bf02806011
  38. 10.1016/S0091-3057(02)00711-6 · DOI
  39. 10.1016/S0893-133X(01)00257-3 · DOI · Paper page
  40. 10.1073/pnas.061369098 · DOI · Paper page
  41. 10.1007/BF02244882 · DOI
  42. First M, 1994, Diagnostic and statistical manual of mental disorders
  43. 10.1007/BF02805972 · DOI · Paper page
  44. 10.1038/379733a0 · DOI · Paper page
  45. 10.1073/pnas.93.24.14065 · DOI · Paper page
  46. 10.1016/S0166-4328(00)00206-0 · DOI · Paper page
  47. 10.1046/j.1471-4159.1999.0721117.x · DOI
  48. Fryer J D, 1999, J Pharmacol Exp Ther, 288, 88
  49. 10.1016/0091-3057(95)02063-2 · DOI
  50. 10.1016/j.tips.2003.11.003 · DOI · Paper page
  51. George T P, 2001, Psychiatr Times, 18, 39
  52. 10.1016/S0006-8993(98)00537-X · DOI
  53. George T P, 2000, J Pharmacol Exp Ther, 295, 58
  54. 10.1016/S0893-133X(01)00296-2 · DOI · Paper page
  55. George T P, 2003, American College of Neuropsychopharmacology
  56. George T P, 2003, Medical illness in schizophrenia
  57. 10.1007/s002130050554 · DOI
  58. 10.1093/bmb/65.1.21 · DOI
  59. 10.1016/S0006-3223(99)00130-4 · DOI · Paper page
  60. 10.4088/JCP.v59n0503 · DOI
  61. 10.1212/WNL.52.1.115 · DOI · Paper page
  62. 10.1093/oxfordjournals.aje.a116960 · DOI · Paper page
  63. 10.1176/ajp.154.6.799 · DOI · Paper page
  64. 10.1007/BF02251289 · DOI · Paper page
  65. 10.1007/s00213-002-1005-6 · DOI · Paper page
  66. 10.1046/j.1471-4159.1996.67051953.x · DOI · Paper page
  67. 10.1016/S0899-3289(20)30005-5 · DOI
  68. 10.1080/14622299050011971 · DOI
  69. 10.1007/s002130000541 · DOI
  70. 10.1037/0022-006X.61.5.743 · DOI · Paper page
  71. 10.1007/s002130050493 · DOI
  72. 10.1016/S0006-8993(97)01135-9 · DOI · Paper page
  73. 10.1017/S1041610201007888 · DOI
  74. 10.1007/s002130000399 · DOI
  75. 10.1146/annurev.pu.10.050189.000555 · DOI
  76. 10.1007/BF02247426 · DOI · Paper page
  77. Kelton M C, 2000, Brain Cognit, 43, 274
  78. 10.1016/S0306-4603(01)00266-0 · DOI
  79. 10.1016/S0091-3057(99)00006-4 · DOI
  80. 10.1159/000054957 · DOI
  81. 10.1007/s002130050109 · DOI
  82. 10.1007/s002130050800 · DOI
  83. 10.1007/s002130050360 · DOI
  84. 10.1001/jama.284.20.2606 · DOI · Paper page
  85. 10.1016/S0896-6273(02)01004-8 · DOI · Paper page
  86. 10.1007/BF02244994 · DOI
  87. 10.1080/14622200110050213 · DOI · Paper page
  88. 10.1001/archpsyc.59.12.1085 · DOI · Paper page
  89. 10.1007/BF02247415 · DOI · Paper page
  90. 10.1002/neu.10151 · DOI · Paper page
  91. 10.1007/s002130050667 · DOI · Paper page
  92. 10.1007/BF02246285 · DOI
  93. 10.1007/BF02246281 · DOI · Paper page
  94. 10.1016/S0893-133X(96)00018-8 · DOI · Paper page
  95. 10.1007/s002130050750 · DOI · Paper page
  96. 10.1016/S0926-6410(98)00044-5 · DOI
  97. 10.1037/1064-1297.9.1.83 · doi:10.1037/1064-1297.9.1.83 · Paper page
  98. Lezak M D, 1995, Neuropsychological assessment
  99. 10.1007/s002130051107 · DOI
  100. 10.1002/neu.10148 · DOI · Paper page
  101. McConville B J, 1991, Am J Psychiatry, 148, 793, 10.1176/ajp.148.6.793 · DOI
  102. 10.1016/0006-3223(92)90315-Q · DOI
  103. 10.1007/s002130100899 · DOI
  104. 10.1016/S0028-3932(98)00012-8 · DOI
  105. 10.1007/BF02247425 · DOI
  106. 10.1038/npp.1994.11 · DOI
  107. 10.2165/00002512-199711030-00005 · DOI · Paper page
  108. 10.1007/BF00174504 · DOI · Paper page
  109. 10.1080/14622299050011371 · DOI
  110. 10.1038/sj.npp.1300173 · DOI
  111. 10.1016/S0893-133X(97)00095-X · DOI
  112. 10.1016/S0165-1781(03)00022-2 · DOI
  113. 10.1016/S0893-133X(99)00098-6 · DOI
  114. 10.1124/mol.54.6.1132 · DOI · Paper page
  115. 10.3109/15622970309167951 · DOI
  116. 10.1159/000118807 · DOI
  117. 10.1007/s004150050299 · DOI · Paper page
  118. 10.1080/1462220021000018425 · DOI
  119. Perkins K A, 1994, J Pharmacol Exp Ther, 270, 628
  120. 10.1007/BF00445565 · DOI
  121. Picciotto M R, 2003, Trends Pharmacol Sci, 23, 494
  122. 10.1007/s002130050722 · DOI
  123. 10.1016/0306-4603(94)90058-2 · DOI
  124. 10.1300/J069v20n01_07 · DOI
  125. 10.1016/0899-3289(95)90030-6 · DOI · Paper page
  126. 10.1046/j.1360-0443.2002.00117.x · DOI
  127. 10.1007/BF02245662 · DOI
  128. 10.1017/S0317167100046321 · DOI
  129. 10.1212/WNL.37.2.226 · DOI
  130. 10.1523/JNEUROSCI.22-21-09604.2002 · DOI
  131. 10.1007/s002210000407 · DOI · Paper page
  132. 10.1002/ana.410190502 · DOI · Paper page
  133. 10.1016/S0014-2999(02)01452-8 · DOI
  134. 10.1097/00008877-200011000-00009 · DOI · Paper page
  135. Sacco K A, 2004, Nicotinic recepter mechanisms and neuropsychological functioning in schizophrenia: effects on spatial working memory and attention
  136. 10.1192/bjp.154.6.797 · DOI · Paper page
  137. 10.1002/hup.424 · DOI
  138. Salin-Pascual R J, 1996, J Clin Psychiatry, 57, 387
  139. 10.1124/jpet.102.045773 · DOI · Paper page
  140. 10.1124/jpet.103.051912 · DOI
  141. 10.1016/S0006-3223(02)01342-2 · DOI
  142. 10.1007/BF02247722 · DOI
  143. 10.3109/15622970209150616 · DOI
  144. 10.1097/00004583-200109000-00020 · DOI
  145. Simon R, 2002, Clinical neurology
  146. 10.1016/S0893-133X(02)00324-X · DOI · Paper page
  147. Snaedal J J T, 1996, Dementia, 7, 47
  148. 10.1016/0376-8716(89)90090-2 · DOI
  149. 10.1177/070674370200601S13 · DOI
  150. 10.1111/j.1360-0443.1994.tb00869.x · DOI
  151. 10.1007/BF02316865 · DOI
  152. 10.1176/ajp.155.8.1009 · DOI · Paper page
  153. 10.1007/s002130050573 · DOI · Paper page
  154. 10.1016/S0014-2999(99)00886-9 · DOI
  155. Suter T W, 1983, Activas Nervosa Superior, 25, 261
  156. 10.1177/026988119200600210 · DOI · Paper page
  157. 10.1124/jpet.102.041616 · DOI · Paper page
  158. 10.1016/S0278-5846(01)00194-4 · DOI
  159. 10.1176/appi.ajp.157.3.368 · DOI · Paper page
  160. 10.1080/10673220127912 · DOI · Paper page
  161. Vezina P, 1992, JPET, 261, 484
  162. Victor M, 2001, Adams and Victor’s principles of neurology
  163. 10.1212/WNL.57.6.1032 · DOI
  164. 10.1159/000109692 · DOI
  165. 10.1016/0091-3057(91)90109-F · DOI
  166. 10.1037/0894-4105.14.3.409 · DOI · Paper page
  167. Weiss M, 2003, adults. Can Med Assoc J, 168, 715
  168. 10.1007/BF00432014 · DOI
  169. 10.1007/s002130000382 · DOI · Paper page
  170. 10.1007/BF00432045 · DOI
  171. 10.1007/s002130050931 · DOI · Paper page
  172. 10.1016/0091-3057(95)00043-V · DOI · Paper page
  173. 10.1523/JNEUROSCI.23-08-03176.2003 · DOI · Paper page
  174. Yang Y K, 2002, Neuropsychpharmacology, 27, 684
  175. 10.1124/jpet.103.048777 · DOI
  176. 10.1177/1073858402239588 · DOI

Cited by

See all 201

Metadata

Authors
Sacco, K. A., Bannon, K. L., & George, T. P.
Venue
Journal of Psychopharmacology
Published
2004-12
Volume
18
Issue
4
Pages
457-474
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W4319292982
Cited by
201
References
21
FWCI
6.34
Type
journal article
Language
en
Open access
green
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. https://app.cochat.ai/papers/10.1177/0269881104047273
The paper
Sacco, K. A., Bannon, K. L., & George, T. P. (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology. https://doi.org/10.1177/0269881104047273

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.